Cutler Group LP Gossamer Bio, Inc. Call Options Transaction History

Cutler Group LP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Jul 18, 2023	BUY	$0.98 - $1.53 $27,832 - $43,452	28,400 Added 28400.0%	28,500 $10,000
Q1 2023 May 01, 2023	SELL	$0.96 - $2.92 $4,512 - $13,724	-4,700 Reduced 97.92%	100 $0
Q4 2022 Feb 07, 2023	BUY	$1.74 - $12.87 $4,524 - $33,462	2,600 Added 118.18%	4,800 $0
Q3 2022 Oct 25, 2022	SELL	$7.21 - $14.88 $12,257 - $25,296	-1,700 Reduced 43.59%	2,200 $6,000
Q2 2022 Aug 04, 2022	BUY	$5.97 - $9.97 $23,283 - $38,883	3,900 New	3,900 $1,000
Q3 2021 Oct 26, 2021	SELL	$7.25 - $13.23 $21,750 - $39,690	-3,000 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$8.0 - $9.75 $4,000 - $4,875	500 Added 20.0%	3,000 $0
Q4 2019 Feb 06, 2020	BUY	$14.82 - $26.79 $35,568 - $64,296	2,400 Added 2400.0%	2,500 $1,000
Q3 2019 Oct 28, 2019	BUY	$16.02 - $22.47 $1,602 - $2,247	100 New	100 $0

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $80.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.